Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 2
1988 2
1989 1
1990 3
1991 4
1992 3
1993 5
1994 3
1995 5
1996 3
1997 4
1998 4
1999 2
2001 4
2002 4
2003 5
2004 6
2005 6
2006 8
2007 4
2008 5
2009 7
2010 4
2012 3
2013 6
2014 3
2015 2
2016 5
2017 3
2018 4
2019 2
2020 4
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates come of age in oncology.
Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Dumontet C, et al. Among authors: senter pd. Nat Rev Drug Discov. 2023 Aug;22(8):641-661. doi: 10.1038/s41573-023-00709-2. Epub 2023 Jun 12. Nat Rev Drug Discov. 2023. PMID: 37308581 Review.
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD. Doronina SO, et al. Among authors: senter pd. Nat Biotechnol. 2003 Jul;21(7):778-84. doi: 10.1038/nbt832. Epub 2003 Jun 1. Nat Biotechnol. 2003. PMID: 12778055
Precision cancer targeting with antibody pairs.
Lawrence RT, Senter PD. Lawrence RT, et al. Among authors: senter pd. Nat Biotechnol. 2022 Oct;40(10):1434-1435. doi: 10.1038/s41587-022-01401-3. Nat Biotechnol. 2022. PMID: 35879363 No abstract available.
Breaking up is hard to do.
Van Epps HA, Senter PD. Van Epps HA, et al. Among authors: senter pd. Nat Chem Biol. 2019 Oct;15(10):934-935. doi: 10.1038/s41589-019-0351-1. Nat Chem Biol. 2019. PMID: 31451759 No abstract available.
Development of Novel Antibody-Camptothecin Conjugates.
Lyski RD, Bou LB, Lau UY, Meyer DW, Cochran JH, Okeley NM, Emmerton KK, Zapata F, Simmons JK, Trueblood ES, Ortiz DJ, Zaval MC, Snead KM, Jin S, Farr LM, Ryan MC, Senter PD, Jeffrey SC. Lyski RD, et al. Among authors: senter pd. Mol Cancer Ther. 2021 Feb;20(2):329-339. doi: 10.1158/1535-7163.MCT-20-0526. Epub 2020 Dec 3. Mol Cancer Ther. 2021. PMID: 33273058
Antibody-drug conjugates in cancer therapy.
Sievers EL, Senter PD. Sievers EL, et al. Among authors: senter pd. Annu Rev Med. 2013;64:15-29. doi: 10.1146/annurev-med-050311-201823. Epub 2012 Oct 3. Annu Rev Med. 2013. PMID: 23043493 Review.
Structure-activity relationships of tubulysin analogues.
Courter JR, Hamilton JZ, Hendrick NR, Zaval M, Waight AB, Lyon RP, Senter PD, Jeffrey SC, Burke PJ. Courter JR, et al. Among authors: senter pd. Bioorg Med Chem Lett. 2020 Jul 15;30(14):127241. doi: 10.1016/j.bmcl.2020.127241. Epub 2020 May 5. Bioorg Med Chem Lett. 2020. PMID: 32527543
Antibody-drug conjugates for cancer therapy.
Carter PJ, Senter PD. Carter PJ, et al. Among authors: senter pd. Cancer J. 2008 May-Jun;14(3):154-69. doi: 10.1097/PPO.0b013e318172d704. Cancer J. 2008. PMID: 18536555 Review.
125 results